4D Molecular Therapeutics, Inc. earnings per share and revenue

FDMT earnings per share for the last quarter are -0.63 USD whereas the estimation was -0.68 USD which accounts for 7.92% surprise. Company revenue for the same period amounts to 5.00 k USD despite the estimated figure of 1.27 M USD. Estimated earnings per share for the next quarter are -0.68 USD, and revenue is expected to reach 1.62 M USD. Also watch annual changes over time to get a bigger picture of FDMT earnings per share and revenue dynamics.